APA (7th ed.) Citation

Ashton, N. J., Janelidze, S., Mattsson-Carlgren, N., Binette, A. P., Strandberg, O., Brum, W. S., . . . Lund University, F. o. M. (2022). Differential roles of Aβ42/40, p-tau231 and p-tau217 for Alzheimer’s trial selection and disease monitoring. Nature Medicine, 28(12), 2555-2562. https://doi.org/10.1038/s41591-022-02074-w

Chicago Style (17th ed.) Citation

Ashton, Nicholas J., et al. "Differential Roles of Aβ42/40, P-tau231 and P-tau217 for Alzheimer’s Trial Selection and Disease Monitoring." Nature Medicine 28, no. 12 (2022): 2555-2562. https://doi.org/10.1038/s41591-022-02074-w.

MLA (9th ed.) Citation

Ashton, Nicholas J., et al. "Differential Roles of Aβ42/40, P-tau231 and P-tau217 for Alzheimer’s Trial Selection and Disease Monitoring." Nature Medicine, vol. 28, no. 12, 2022, pp. 2555-2562, https://doi.org/10.1038/s41591-022-02074-w.